0001683168-17-000666.txt : 20170327
0001683168-17-000666.hdr.sgml : 20170327
20170327160512
ACCESSION NUMBER: 0001683168-17-000666
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20170327
DATE AS OF CHANGE: 20170327
EFFECTIVENESS DATE: 20170327
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Rennova Health, Inc.
CENTRAL INDEX KEY: 0000931059
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734]
IRS NUMBER: 680370244
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-283386
FILM NUMBER: 17715409
BUSINESS ADDRESS:
STREET 1: 400 S. AUSTRALIAN AVENUE, SUITE 800
CITY: WEST PALM BEACH
STATE: FL
ZIP: 33401
BUSINESS PHONE: 561-855-1626
MAIL ADDRESS:
STREET 1: 400 S. AUSTRALIAN AVENUE, SUITE 800
CITY: WEST PALM BEACH
STATE: FL
ZIP: 33401
FORMER COMPANY:
FORMER CONFORMED NAME: CollabRx, Inc.
DATE OF NAME CHANGE: 20120926
FORMER COMPANY:
FORMER CONFORMED NAME: TEGAL CORP /DE/
DATE OF NAME CHANGE: 19950918
D
1
primary_doc.xml
X0707
D
LIVE
0000931059
Rennova Health, Inc.
400 SOUTH AUSTRALIAN AVENUE, SUITE 800
WEST PALM BEACH
FL
FLORIDA
33401
561-855-1626
DELAWARE
None
CollabRx, Inc.
TEGAL CORP /DE/
Corporation
true
Seamus
Lagan
400 S. Australian Avenue, Suite 800
West Palm Beach
FL
FLORIDA
33401
Executive Officer
Director
Paul
Billings
400 S. Australian Avenue, Suite 800
West Palm Beach
FL
FLORIDA
33401
Director
Christopher
Diamantis
400 S. Australian Avenue, Suite 800
West Palm Beach
FL
FLORIDA
33401
Director
Michael
L
Goldberg
400 S. Australian Avenue, Suite 800
West Palm Beach
FL
FLORIDA
33401
Director
Robert
Lee
400 S. Australian Avenue, Suite 800
West Palm Beach
FL
FLORIDA
33401
Director
Other Health Care
Decline to Disclose
- 06b
false
2017-03-13
false
true
false
1
848000
848000
0
Holders of $440,000 principal amount of convertible notes and warrants exchanged such securities for an aggregate of 400,000 shares of common stock (closing price on 3/13/2017 was $2.12 per share).
false
2
0
0
0
The shares of common stock are being issued in exchange for convertible notes and warrants. No gross proceeds will be received upon the issuance of the shares of common stock.
false
Rennova Health, Inc.
/s/ Seamus Lagan
Seamus Lagan
Chief Executive Officer
2017-03-27